| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |